1Chinetti G,Griglio S.Antonucci M,et al.Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem,1998,273:25573-25580.
2Ricote M,Li AC,Willson TM,et al.The Peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.Nature,1998,391:79-82.
3Neve BP,Fruchart JC,Staels B,et al.Role of the peroxisome proliferator-activated receptors(PPAR)in atherosclerosis.Biochem-Pharmacol,2000,60:1245-1250.
4Lehmann JM,Moore LB,Smith-Oliver TA,et al.An antidiabetic thiazolidinedione is high affinity ligand for peroxisome proliferator-activated receptort γ(PPARγ).J Biol Chem,1995,270:12953-12956.
5Komers R,Vrana A.Thiazolidinediones-tools for the research of metabolic syndrome X.Physiol-Res,1998,47:215-225.
6Martens FM,Visseren FL,Lemay J,et al.Metabolic and additional vascular effects of thiazolidinediones.Drugs,2002,62:1463-1480.
7Ogihara T,Rakugi H,Ikegami H,et al.Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.Am J Hypertens,1995,8:316-320.
8Diep QN,E1-Mabrouk M,Cohn JS,et al.Structure,endothelial function,cell growth,and inflammation in blood vessels of angiotension Ⅱ-infused rats:role of peroxisome proliferator-activated receptor-gamma.Circulation,2002,105:2296-2302.
9Zhang F,Sowers JR,Ram JL,et al.Effects of pioglitazone on calcium channels in vascular smooth musele.Hypertension,1994,24:170-175.
10Buchanan TA,Meehan WP,Jeng YY,et al.Blood pressure lowering by pioglitazone.Evidence for a direct vascular effect.J Clin Invest,1995,96:354-360.
